| Autor: |
Stanziola A. A., Salzano A., D'Angelo R., Marra A. M., Gallotti L., D'Assante R., Pentangelo D., Ranieri B., Bossone E., Cittadini A. |
| Přispěvatelé: |
Stanziola, A. A., Salzano, A., D'Angelo, R., Marra, A. M., Gallotti, L., D'Assante, R., Pentangelo, D., Ranieri, B., Bossone, E., Cittadini, A. |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Open Medicine. 17:689-693 |
| ISSN: |
2391-5463 |
| Popis: |
The present report investigates the impact of a Telemedicine Service (TMS) on the management of Idiopathic Pulmonary Fibrosis (IPF) during coronavirus disease of 2019 (COVID-19) outbreak in Italy. The TMS comprised 3 phone numbers, active 12 h per day, and an email address, monitored every 4 h by trained physicians; chat- and videoconference-services were also offered. At the end of the study period, our staff contacted all patients, to get information about the final outcome (i.e. composite hospitalisations/all causes of death). Outcomes were compared with a cohort of patients who attended our unit in the same period of the previous year (when no TMS was available). 189 patients participated in the present study. From 11th March to 4th May 2020, 61% of patients made at least one TMS access, mostly by emails (53%), followed by phone calls (33%). With regard to the primary outcome, TMS patients experienced a significant lower rate of events of the 182 patients of the no-TMS cohort (p < 0.001). Specifically, a significant difference was observed for IPF hospitalisation (p < 0.001) whereas no differences were observed with regard to deaths (p = 0.64). TMS permits patients to be followed up even during COVID-19 lockdown, with an encouraging impact on outcomes. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
